Hedging Ironwood before ruling

By
A A A

One investor is hedging a position in Ironwood Pharmaceuticals before a regulatory ruling next month.

optionMONSTER's Depth Charge monitoring system detected the purchase of 1,200 September 10 puts for $0.60 and the sale of an equal number of September 15 calls for $0.45. Volume exceeded open interest at both strikes, indicating that a new position was opened.

The trade cost $0.15 and will make money if the drug developer drops toward $10 in the near term. It also obligates the investor to sell shares for $15 if they go that high, so he or she is probably owns the shares.

IRWD rose 1.68 percent to $12.71 yesterday, and has been fluctuating in a range for the last year. The Food & Drug Administration is expected to approve or reject the company's linaclotide intestinal drug in September. The decision could significantly move the stock, which explains why investors are seeking protection.

The trade pushed overall option volume in the name to 23 times greater than average.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.


This article appears in: Investing , Options

Referenced Stocks: IRWD

optionMONSTER

optionMONSTER

More from optionMONSTER:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com